Our Team

We are scientists, entrepreneurs and drug developers with a goal to develop ELOVL2 based therapeutics to slow or halt aging-related disorders.

Management

Martin Emanuele, Ph.D.
Martin Emanuele, Ph.D.
Co-Founder and CEO
Christopher Chavez, Ph.D.
Christopher Chavez, Ph.D.
VP, Head of Synthetic Biology

Scientific Co-Founders

Dorota Skowronska-Krawczyk, Ph.D.
Dorota Skowronska-Krawczyk, Ph.D.
Daniel L. Chao, M.D., Ph.D.
Daniel L. Chao, M.D., Ph.D.

Board Of Directors

Arthur Becker
Arthur Becker
Eric Carter, M.D., Ph.D.
Eric Carter, M.D., Ph.D.
Elaine J. Heron, Ph.D.
Elaine J. Heron, Ph.D.
Thomas Meier, Ph.D.
Thomas Meier, Ph.D.
Santosh Vetticaden, M.D., Ph.D.
Santosh Vetticaden, M.D., Ph.D.
Martin Emanuele, Ph.D.
Martin Emanuele, Ph.D.

Mission In Focus.

Learn more about our goal to develop ELOVL2 based therapeutics to slow or halt aging-related disorders.

Contact Us »